Amy has a background in nanoparticle delivery platforms for nucleic acids and gene editing technologies. She completed her PhD at UCL Institute of Child Health with a Fellowship at University of British Columbia and McGill University, Montreal. Amy joined 4basebio in 2020 where she is now Vice President of Research. Amy is an experienced speaker form both national and international conferences.